This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andes, D.
Right arrow Articles by Pitula, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andes, D.
Right arrow Articles by Pitula, A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

 Previous Article  |  Next Article 

Infection and Immunity, October 2004, p. 6023-6031, Vol. 72, No. 10
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.10.6023-6031.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Development and Characterization of an In Vivo Central Venous Catheter Candida albicans Biofilm Model

D. Andes,1,2* J. Nett,1 P. Oschel,3 R. Albrecht,3 K. Marchillo,1 and A. Pitula1

Department of Medicine,1 Department of Medical Microbiology and Immunology,2 Biological and Biomaterials Preparation, Imaging, and Characterization Laboratory, Department of Animal Science, University of Wisconsin, Madison, Wisconsin3

Received 14 May 2004/ Accepted 16 June 2004

Biofilms represent a niche for microorganisms where they are protected from both the host immune system and antimicrobial therapies. Biofilm growth serves as an increasing source of clinical infections. Candida infections are difficult to manage due to their persistent nature and associated drug resistance. Observations made in biofilm research have generally been limited to in vitro models. Using a rat central venous catheter model, we characterized in vivo Candida albicans biofilm development. Time-course quantitative culture demonstrated a progressive increase in the burden of viable cells for the first 24 h of development. Fluorescence and scanning electron microscopy revealed a bilayered architecture. Adjacent to the catheter surface, yeast cells were densely embedded in an extracellular matrix. The layer adjacent to the catheter lumen was less dense. The outermost surface of the biofilm contained both yeast and hyphal forms, and the extracellular material in which they were embedded appeared fibrous. These architectural features were similar in many respects to those described for in vitro models. However, scanning electron microscopy also revealed host cells embedded within the biofilm matrix. Drug susceptibility was determined by using two assays and demonstrated a biofilm-associated drug resistance phenotype. The first assay demonstrated continued growth of cells in the presence of supra-MIC antifungal drug concentrations. The second assay demonstrated reduced susceptibility of biofilm-grown cells following removal from the biofilm structure. Lastly, the model provided sufficient nucleic material for study of differential gene expression associated with in vivo biofilm growth. Two fluconazole efflux pumps, CDR1 and CDR2, were upregulated in the in vivo biofilm-associated cells. Most importantly, the studies described provide a model for further investigation into the molecular mechanisms of C. albicans biofilm biology and drug resistance. In addition, the model provides a means to study novel drug therapies and device technologies targeted to the control of biofilm-associated infections.

* Corresponding author. Mailing address: University of Wisconsin, Departments of Medicine and Medical Microbiology Immunology, 600 Highland Ave., Room H4/572, Madison, WI 53792. Phone: (608) 263-1415. Fax: (608) 263-4464. E-mail: dra{at}medicine.wisc.edu.

Editor: T. R. Kozel

Infection and Immunity, October 2004, p. 6023-6031, Vol. 72, No. 10
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.10.6023-6031.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Ferreira, J. A. G., Carr, J. H., Starling, C. E. F., de Resende, M. A., Donlan, R. M. (2009). Biofilm Formation and Effect of Caspofungin on Biofilm Structure of Candida Species Bloodstream Isolates. Antimicrob. Agents Chemother. 53: 4377-4384 [Abstract] [Full Text]  
  • Lazzell, A. L., Chaturvedi, A. K., Pierce, C. G., Prasad, D., Uppuluri, P., Lopez-Ribot, J. L. (2009). Treatment and prevention of Candida albicans biofilms with caspofungin in a novel central venous catheter murine model of candidiasis. J Antimicrob Chemother 64: 567-570 [Abstract] [Full Text]  
  • Venkatesh, M., Rong, L., Raad, I., Versalovic, J. (2009). Novel synergistic antibiofilm combinations for salvage of infected catheters. J Med Microbiol 58: 936-944 [Abstract] [Full Text]  
  • Stichternoth, C., Ernst, J. F. (2009). Hypoxic Adaptation by Efg1 Regulates Biofilm Formation by Candida albicans. Appl. Environ. Microbiol. 75: 3663-3672 [Abstract] [Full Text]  
  • Nett, J. E., Guite, K. M., Ringeisen, A., Holoyda, K. A., Andes, D. R. (2008). Reduced Biocide Susceptibility in Candida albicans Biofilms. Antimicrob. Agents Chemother. 52: 3411-3413 [Abstract] [Full Text]  
  • Xu, Y., Chen, L., Li, C. (2008). Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations. J Antimicrob Chemother 61: 798-804 [Abstract] [Full Text]  
  • Uppuluri, P., Nett, J., Heitman, J., Andes, D. (2008). Synergistic Effect of Calcineurin Inhibitors and Fluconazole against Candida albicans Biofilms. Antimicrob. Agents Chemother. 52: 1127-1132 [Abstract] [Full Text]  
  • Yeater, K. M., Chandra, J., Cheng, G., Mukherjee, P. K., Zhao, X., Rodriguez-Zas, S. L., Kwast, K. E., Ghannoum, M. A., Hoyer, L. L. (2007). Temporal analysis of Candida albicans gene expression during biofilm development. Microbiology 153: 2373-2385 [Abstract] [Full Text]  
  • Perumal, P., Mekala, S., Chaffin, W. L. (2007). Role for Cell Density in Antifungal Drug Resistance in Candida albicans Biofilms. Antimicrob. Agents Chemother. 51: 2454-2463 [Abstract] [Full Text]  
  • Li, F., Svarovsky, M. J., Karlsson, A. J., Wagner, J. P., Marchillo, K., Oshel, P., Andes, D., Palecek, S. P. (2007). Eap1p, an Adhesin That Mediates Candida albicans Biofilm Formation In Vitro and In Vivo. Eukaryot Cell 6: 931-939 [Abstract] [Full Text]  
  • Jain, N., Kohli, R., Cook, E., Gialanella, P., Chang, T., Fries, B. C. (2007). Biofilm Formation by and Antifungal Susceptibility of Candida Isolates from Urine. Appl. Environ. Microbiol. 73: 1697-1703 [Abstract] [Full Text]  
  • Nett, J., Lincoln, L., Marchillo, K., Massey, R., Holoyda, K., Hoff, B., VanHandel, M., Andes, D. (2007). Putative Role of {beta}-1,3 Glucans in Candida albicans Biofilm Resistance. Antimicrob. Agents Chemother. 51: 510-520 [Abstract] [Full Text]  
  • Khot, P. D., Suci, P. A., Miller, R. L., Nelson, R. D., Tyler, B. J. (2006). A Small Subpopulation of Blastospores in Candida albicans Biofilms Exhibit Resistance to Amphotericin B Associated with Differential Regulation of Ergosterol and {beta}-1,6-Glucan Pathway Genes. Antimicrob. Agents Chemother. 50: 3708-3716 [Abstract] [Full Text]  
  • Nobile, C. J., Nett, J. E., Andes, D. R., Mitchell, A. P. (2006). Function of Candida albicans Adhesin Hwp1 in Biofilm Formation.. Eukaryot Cell 5: 1604-1610 [Abstract] [Full Text]  
  • Mukherjee, P. K., Mohamed, S., Chandra, J., Kuhn, D., Liu, S., Antar, O. S., Munyon, R., Mitchell, A. P., Andes, D., Chance, M. R., Rouabhia, M., Ghannoum, M. A. (2006). Alcohol Dehydrogenase Restricts the Ability of the Pathogen Candida albicans To Form a Biofilm on Catheter Surfaces through an Ethanol-Based Mechanism. Infect. Immun. 74: 3804-3816 [Abstract] [Full Text]  
  • Ramage, G., Saville, S. P., Thomas, D. P., Lopez-Ribot, J. L. (2005). Candida Biofilms: an Update. Eukaryot Cell 4: 633-638 [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»